Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
BTK (Bruton Tyrosine Kinase)
i
Other names:
BTK, Bruton Tyrosine Kinase, Bruton Agammaglobulinemia Tyrosine Kinase, Tyrosine-Protein Kinase BTK, Bruton'S Tyrosine Kinase, B-Cell Progenitor Kinase, AGMX1, ATK, BPK, Tyrosine-Protein Kinase BTK Isoform (Lacking Exon 13 To 17), Dominant-Negative Kinase-Deficient Brutons Tyrosine Kinase, Tyrosine-Protein Kinase BTK Isoform (Lacking Exon 14), Truncated Bruton Agammaglobulinemia Tyrosine Kinase, Agammaglobulinaemia Tyrosine Kinase, Agammaglobulinemia Tyrosine Kinase, PSCTK1, IGHD3, IMD1, XLA, AT
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
695
Related tests:
‹
Oncomine™ Comprehensive Assay v3M (2)
PredicineHEME™
SureSeq CLL + CNV V3 NGS Panel
SureSeq™ CLL + CNV Panel
SureSeq™ Pan-Myeloid Panel
Tempus xF Assay
Oncomine™ Comprehensive Assay v3M (2)
PredicineHEME™
SureSeq CLL + CNV V3 NGS Panel
SureSeq™ CLL + CNV Panel
SureSeq™ Pan-Myeloid Panel
Tempus xF Assay
›
Associations
(29)
News
Trials
VERI cancer hierarchy
Reset Filters
BTK C481S
Chronic Lymphocytic Leukemia
BTK C481S
Chronic Lymphocytic Leukemia
acalabrutinib
Resistant: A2 - Guideline
acalabrutinib
Resistant
:
A2
acalabrutinib
Resistant: A2 - Guideline
acalabrutinib
Resistant
:
A2
BTK mutation
Chronic Lymphocytic Leukemia
BTK mutation
Chronic Lymphocytic Leukemia
venetoclax
Sensitive: C3 – Early Trials
venetoclax
Sensitive
:
C3
venetoclax
Sensitive: C3 – Early Trials
venetoclax
Sensitive
:
C3
BTK C481S
Chronic Lymphocytic Leukemia
BTK C481S
Chronic Lymphocytic Leukemia
pirtobrutinib
Sensitive: C3 – Early Trials
pirtobrutinib
Sensitive
:
C3
pirtobrutinib
Sensitive: C3 – Early Trials
pirtobrutinib
Sensitive
:
C3
BTK C481S
Chronic Lymphocytic Leukemia
BTK C481S
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
BTK C481S + PLCG2 D1140N
Chronic Lymphocytic Leukemia
BTK C481S + PLCG2 D1140N
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
BTK C481S + PLCG2 D1140G
Chronic Lymphocytic Leukemia
BTK C481S + PLCG2 D1140G
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
BTK C481S + PLCG2 L845F
Chronic Lymphocytic Leukemia
BTK C481S + PLCG2 L845F
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
BTK C481R
Chronic Lymphocytic Leukemia
BTK C481R
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
BTK C481Y
Chronic Lymphocytic Leukemia
BTK C481Y
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
BTK R665W
Chronic Lymphocytic Leukemia
BTK R665W
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
BTK C481S + BTK R665W + BTK L845F + BTK S707Y
Chronic Lymphocytic Leukemia
BTK C481S + BTK R665W + BTK L845F + BTK S707Y
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
BTK mutation
Chronic Lymphocytic Leukemia
BTK mutation
Chronic Lymphocytic Leukemia
BTK inhibitor
Sensitive: C3 – Early Trials
BTK inhibitor
Sensitive
:
C3
BTK inhibitor
Sensitive: C3 – Early Trials
BTK inhibitor
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.